• Info
  • Significant Ownership

Significant Ownership of L.P. Frazier Life Sciences IX

Signature - Title
/s/ Jennifer Martin - By Jennifer Martin, CFO of FHMLS IX, L.L.C., GP of FHMLS IX, L.P., GP of Frazier Life Sciences IX, L.P.
Location
Seattle, WA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by L.P. Frazier Life Sciences IX.

Notify me when L.P. Frazier Life Sciences IX files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of L.P. Frazier Life Sciences IX

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MIRM MIRUM PHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share 6.8% $324,522,832 +$29,477,804 4,108,404 +10% Patrick J. Heron 23 Jan 2026

Schedules 13D/G Reported by L.P. Frazier Life Sciences IX:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.